Research Article
Urinary Tract Infections in the First 6 Months after Renal Transplantation
Table 1
Patients’ characteristics.
| Pt characteristics | Total | No UTI | UTI | | 279 | 97 | 182 |
| Age | 43.4 ± 15.8 | 42.1 ± 15.6 | 45.8 ± 16.0 | 0.063 | Gender | Male | 165 | 128 | 37 | <0.001 | 59.10% | 70.30% | 38.10% | Female | 114 | 54 | 60 | 40.90% | 29.70% | 61.90% |
| Diabetes mellitus | 95 | 59 | 36 | 0.507 | 34.10% | 32.40% | 37.10% | Type I | 25 | 19 | 6 | 0.099 | 26.60% | 32.80% | 16.70% | Type II | 69 | 39 | 30 | 73.40% | 67.20% | 83.30% |
| Donor type | Deceased | 55 | 34 | 21 | 0.636 | 19.70% | 18.70% | 21.60% | Living | 224 | 148 | 76 | 80.30% | 81.30% | 78.40% |
| Transplant abroad | 21 | 9 | 12 | 0.032 | 7.50% | 4.90% | 12.40% |
| Pretransplant residual urine volume | 24-hour urine volume | Anuria | 68 | 45 | 23 | 0.805 | 24.40% | 24.70% | 23.70% | Oliguria | 41 | 29 | 12 | 14.70% | 15.90% | 12.40% | Normal | 62 | 38 | 24 | 22.20% | 20.90% | 24.70% |
| Preexisting urological abnormalities | Treated urethral stricture | 11 | 9 | 2 | 0.340 | 3.90% | 4.90% | 2.10% | Vesicoureteral reflux ( VUR) | 7 | 3 | 4 | 0.242 | 2.50% | 1.60% | 4.10% | Neurogenic bladder | 10 | 3 | 7 | 0.023 | 3.60% | 1.60% | 7.20% |
| Foley catheter | Foley catheter removal time | 5.8 ± 2.0 | 5.7 ± 1.9 | 6.1 ± 2.3 | 0.120 | Foley catheter reinsertion | 6 | 3 | 3 | 0.668 | 2.20% | 1.70% | 3.10% |
| Serum creatinine in mmol/L | At 1 month | 103.7 ± 47.2 | 105.1 ± 49.1 | 101.0 ± 43.5 | 0.493 | At 6 months | 99.0 ± 34.0 | 100.4 ± 34.9 | 96.4 ± 32.4 | 0.352 |
| Immunosuppression status | Induction therapy | Basiliximab | 107 | 72 | 35 | 0.607 | 38.40% | 39.60% | 36.10% | Thymoglobulin (ATG) | 172 | 110 | 62 | 61.60% | 60.40% | 63.90% | Rejection within 6 months | 22 | 14 | 8 | 1 | 7.90% | 7.70% | 8.20% | Detected polyoma viremia | 19 | 14 | 5 | 0.467 | 6.80% | 7.70% | 5.20% |
| UTI antibiotic prophylaxis | TMP/SMX double strength + norfloxacin | 70 | 49 | 21 | 0.385 | 25.10% | 26.90% | 21.60% | TMP/SMX single strength | 209 | 133 | 76 | 74.90% | 73.10% | 78.40% |
| Stent removal time (days) | Stent removal time (days) | 35.3 ± 28.0 | 34.2 ± 28.7 | 37.3 ± 26.8 | 0.376 |
| Urgent stent removal due to non-UTI reasons | Stent migration to urethra | 6 | 5 | 1 | <0.011 | 2.1% | 1.8% | 0.30% |
| Postrenal transplant surgical complications | Urine leak | 3 | 1 | 2 | 0.554 | 1.10% | 0.50% | 2.10% | Ureteral stenosis | 6 | 3 | 3 | 0.668 | 2.20% | 1.60% | 3.10% |
|
|
Continuous data were reported as (mean ± SD) , and categorical data were reported as numbers and percentages. †Detected polyoma viremia >50 copies/ml. |